04-17-2020, 03:31 PM
Something doesn't make sense about this article:
Pretty sure that a phase III trial would require a placebo arm. If it is this study:
https://clinicaltrials.gov/ct2/show/NCT0...w=2&rank=4
It was a controlled open-label study as best I can tell from the clinicaltrials.org page, so maybe they were just discussing the patients they knew who got remdisivir.
Bc
Quote:The University of Chicago Medicine recruited 125 people with Covid-19 into Gilead's two Phase 3 clinical trials. Of those people, 113 had severe disease. All the patients have been treated with daily infusions of remdesivir.
Pretty sure that a phase III trial would require a placebo arm. If it is this study:
https://clinicaltrials.gov/ct2/show/NCT0...w=2&rank=4
It was a controlled open-label study as best I can tell from the clinicaltrials.org page, so maybe they were just discussing the patients they knew who got remdisivir.
Bc